Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Women who have been assessed as suitable candidates for weight-loss (bariatric) surgery, with a BMI over 40, or a BMI over 35 with at least one related health condition that surgery could help improve
- Women aged between 18 and 45 years old
- Women using an effective form of contraception, such as the oral contraceptive pill, a hormonal or non-hormonal IUD (coil), or a hormonal implant — the method used may need to be adjusted around the time of surgery in line with current medical guidelines
- Women who are enrolled in the French social security system
- Women who have signed a form giving their informed consent to participate
Who may not be able to join:
- Women who are currently pregnant (confirmed by a urine test) or breastfeeding
- Women with a known allergy or intolerance to a medication called cholestyramine
- Women who experience long-term or ongoing constipation
- Women with certain ongoing health conditions that could interfere with how the treatment works — including poorly controlled diabetes (with a specific blood marker above a certain level), a known and treated cholesterol or lipid condition, reduced kidney function, or reduced liver function (confirm with trial site for specific thresholds)
- Women currently taking, or likely to need within three months of joining, certain medications including blood-thinning tablets (anti-vitamin K), digoxin (a heart medication), or levothyroxine (a thyroid medication)
- Women with a condition called phenylketonuria, which affects how the body processes certain proteins
- Women who are not able to give informed consent for any reason
- Women who are under a legal protection arrangement, such as guardianship or curatorship
- Women whose liberty has been restricted by a court or government decision
- Women receiving psychiatric care in a way that prevents them from freely consenting to participate, or who are hospitalised involuntarily
- Women already taking part in another interventional clinical study (other than one called the PaCO project)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nicolas CHEVALIER, Centre Hospitalier Universitaire de Nice
Phone: 04 92 03 55 19
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Measurement of serum persistent organic pollutants (POPs) concentrations by mass spectrometry.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.